Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page.

Healthcare-Related Charitable Support

Genentech is committed to supporting programs open to a broad audience that benefit patients, the scientific or medical community and/or public health.

Important Notice

Genentech is committed to supporting our existing grantees during the evolving coronavirus (COVID-19) pandemic. We understand that grantees will have their own challenges in adapting to rapidly changing events, and we will work to accommodate needs for the programs funded by Genentech.

If you are an existing grantee, please contact your Genentech representative with questions or to let us know if your program or event will be cancelled or postponed. If you are unsure of who to contact, please email [email protected] and we will direct you to the appropriate person.

To learn more about Genentech’s efforts during the pandemic, please visit our COVID-19 response page.

Call for Grants

Genentech is actively seeking applications for the following areas:

Click on a link below for more information and detailed instructions on submitting a Call for Grant Notification (CGN) application.

These support requests are healthcare-related and are consistent with a therapeutic or technological area in which Genentech or Roche is active.

Decision Making

Genentech has a rolling review policy when evaluating funding requests for healthcare-related charitable support. This allows qualified requestors the opportunity to apply anytime during year.

Requests must be submitted at least 60 days prior to the project/program start date. Decisions are made on a case-by-case basis; you will usually hear back from Genentech prior to the project/program start date. Please refrain from submitting applications for which the project/program start date is more than 6 months out. Early submissions will not ensure an early decision.

Letter of Agreement (LOA)

All grants must abide by the terms in the Genentech Letter of Agreement (LOA), which is issued to an authorized signer of your organization once the application is approved. You must agree to the terms of the LOA before any funding is issued.

If you have any questions on the agreement terms, please email us at [email protected] or call (877) 313-5778.

Note: The funding application site does not support IE8 or earlier